Access to anti-retroviral drugs, female in Mozambique
Mozambique: Access to anti-retroviral drugs, female was 85.0% in 2024. ◆ Volatile
Access to anti-retroviral drugs, female in Mozambique, 2000–2024
Source: UNAIDS estimates. Measured in %.
Analysis
Mozambique recorded 85.0% for access to anti-retroviral drugs, female in 2024. That is the highest value across all 25 years on record.
That represents a change of up 4.9% on the previous year and up 117.9% over ten years.
Over the whole period, access to anti-retroviral drugs, female in Mozambique peaked at 85.0% in 2024 and was at its lowest, 0.0%, in 2000.
That places Mozambique 49th out of 141 countries with data for 2024, putting it in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Access to anti-retroviral drugs, female in Mozambique, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 0.0% | — |
| 2004 | 1.0% | — |
| 2005 | 1.0% | +0.0% |
| 2006 | 3.0% | +200.0% |
| 2007 | 7.0% | +133.3% |
| 2008 | 10.0% | +42.9% |
| 2009 | 12.0% | +20.0% |
| 2010 | 15.0% | +25.0% |
| 2011 | 18.0% | +20.0% |
| 2012 | 20.0% | +11.1% |
| 2013 | 29.0% | +45.0% |
| 2014 | 39.0% | +34.5% |
| 2015 | 47.0% | +20.5% |
| 2016 | 56.0% | +19.1% |
| 2017 | 62.0% | +10.7% |
| 2018 | 62.0% | +0.0% |
| 2019 | 66.0% | +6.5% |
| 2020 | 68.0% | +3.0% |
| 2021 | 72.0% | +5.9% |
| 2022 | 77.0% | +6.9% |
| 2023 | 81.0% | +5.2% |
| 2024 | 85.0% | +4.9% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 3.4% | 0.0% | 12.0% | 10 |
| 2010s | 41.4% | 15.0% | 66.0% | 10 |
| 2020s | 76.6% | 68.0% | 85.0% | 5 |
Countries ranked near Mozambique
- 47 Iceland 86.0% compare
- 47 Peru 86.0% compare
- 50 Côte d'Ivoire 84.0% compare
- 50 Singapore 84.0% compare
- 50 South Africa 84.0% compare
More gender data for Mozambique
- Child population (UN estimates and projections) 17,379 (2030)
- Child population (UN estimates and projections) (0-14), annual growth 1.93 % change on previous year (2030)
- Population 23,468 (2030)
- Working-age population (UN estimates and projections) 23,468 (2030)
- Population (UN estimates and projections), annual growth rate 3.27 % change on previous year (2030)
- Age population, age 00, female, interpolated 617,774 (2025)
- Age population, age 00, male, interpolated 625,212 (2025)
- Age population, age 01, female, interpolated 598,653 (2025)
- Age population, age 01, male, interpolated 605,099 (2025)
- Age population, age 02, female, interpolated 585,024 (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, female in Mozambique?
- Access to anti-retroviral drugs, female in Mozambique was 85.0% in 2024, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, female recorded in Mozambique?
- The highest recorded value was 85.0% in 2024.
- What is the lowest access to anti-retroviral drugs, female recorded in Mozambique?
- The lowest recorded value was 0.0% in 2000.
- How does Mozambique rank for access to anti-retroviral drugs, female?
- Mozambique ranks 49th out of 141 countries with data for 2024.
- Is access to anti-retroviral drugs, female rising or falling in Mozambique?
- Over the last ten years it is up 117.9%. The long-run trend across the full record is volatile.
- Where does this Mozambique data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, female (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.